(Q43929509)

28 November 2017

title

Evolution of homocysteine during ovarian stimulation for IVF or ICSI (English)

1 reference

28 November 2017

Bettahar-Lebugle K

1

1 reference

28 November 2017

Feugeas O

2

1 reference

28 November 2017

Wittemer C

3

1 reference

28 November 2017

Ohl J

4

1 reference

28 November 2017

Rongières C

5

1 reference

28 November 2017

Nisand I

6

1 reference

28 November 2017

publication date

1 February 2002

1 reference

Gynécologie, obstétrique & fertilité

28 November 2017

published in

1 reference

28 November 2017

volume

30

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

121-128

1 reference

Upper limb thrombosis associated with assisted conception treatment

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Diagnosis, prevention and management of ovarian hyperstimulation syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Moderate ovarian hyperstimulation syndrome complicated by deep cerebrovascular thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Relationship between homocysteine and thrombotic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Newborn screening for homocystinuria: Irish and world experience

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Molecular genetics of methylenetetrahydrofolate reductase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Severe ovarian hyperstimulation syndrome: role of peripheral vasodilation.

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

The pathogenesis of the ovarian hyperstimulation syndrome (OHS): a possible role for ovarian renin

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

The role of prostaglandins in ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Does ovarian stimulation for in-vitro fertilization induce a hypercoagulable state?

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Response of blood coagulation parameters to elevated endogenous 17 beta-estradiol levels induced by human menopausal gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

von Willebrand factor: an endothelial marker to monitor in-vitro fertilization patients with ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Severe ovarian hyperstimulation syndrome and deep venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

Thromboembolic disease in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1297-9589%2801%2900278-8

7 January 2021

10.1016/S1297-9589(01)00278-8

Identifiers

DOI

1 reference

28 November 2017

1 reference